Idiopathic inflammatory myopathy

• An Open-Label, Phase 1b, Multiple Ascending Dose Study of OM336 in Participants with Active Sjogren’s Disease or Idiopathic Inflammatory Myo … Pending
  2025-524100-29-00 3 "Seropositive autoimmune disease: Sjogren’s disease or idiopa"
• A Long-Term Follow-up Study for Subjects Previously Treated with A Century Therapeutics Cellular Therapy Product Recruiting
  2024-520222-11-00 3 2026-03-03 "Hematological or solid tumor malignancies or autoimmune dise"
• An open label, phase I/II study investigating the safety and efficacy of the bispecific T-cell engaging antibody cizutamig (BCMAxCD3) in pat … Recruiting
  2025-522857-20-00 9 2026-01-22 "Severe, treatment refractory primary Sjögren’s disease (pSjD"
• A phase I/II study of CAR-T cells in AutoiMmune disease resistant to B cell Abrogation - CARAMBA Recruiting
  2025-521530-28-00 9 2026-01-19 "Progressive systemic autoimmune disease resistant to B cell "
• A Phase 1 Study of the Safety and Preliminary Efficacy of CTX112 in Adult Subjects With Refractory Autoimmune Disease. Recruiting
  2024-518528-54-00 1 2025-12-02 "Active systemic lupus erythematosus (SLE), systemic sclerosi"
• A Phase 1 Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants with Severe, Refractory Autoimmune Diseases Recruiting
  2024-517681-41-00 1 2025-08-29 "Systemic Sclerosis"
• A phase I/II study of CAR-expressing Allogenic iPSC derived NK cells for treatment of autoiMmune disease by B cELl depletion - CARAMEL Recruiting
  2024-519532-16-00 9 2025-07-30 "Idiopathic inflammatory myositis"
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants with Systemic Lupus Ery … Recruiting
  2024-519015-34-00 1 2025-06-30 "Systemic Lupus Erythematosus"
• An open-label extension study with dazukibart for participants with idiopathic inflammatory myopathies (including DM or PM) who have complet … Recruiting
  2024-514648-10-00 5 2025-03-14 "Idiopathic Inflammatory Myopathy (including dermatomyositis "
• CAR-T cells in systemic B cell mediated autoimmune disease - CASTLE Recruiting
  2024-516819-24-00 9 2023-05-16 "Systemic Sclerosis"
• A study to investigate the efficacy and safety of efgartigimod PH20 SC in adult participants with active idiopathic inflammatory myopathy Recruitment ended
  2024-512785-33-00 10 2023-03-01 "Active Idiopathic Inflammatory Myopathy (IIM)"
• A Phase 1 Study of CD19-targeted NEX-T CAR T Cells in Participants with Severe, Refractory Autoimmune Diseases (Breakfree-1) Halted
  2023-503823-24-01 3 2024-04-15 "Systemic Sclerosis"
• The CALiPSO-1 Study: A Study of CNTY-101, a CD19-targeted CAR iNK Cell Product, in Participants with Refractory B cell-mediated Autoimmune D … Ended
  2024-518797-13-00 3 2025-07-10 "systemic lupus erythematosus [SLE]/lupus nephritis [LN], idi"

Showing 1–13 of 13 trials